TBH I'm surprised how hard Illumina is already pushing Galleri as a product. Current ctDNA/cfDNA are imperfect for advanced cancers which should have a lot of shedding to begin with. Additionally CHIP is and outstanding issue. DNA methylation sequencing has promise but I feel more data would be needed to truly make diagnostic findings. So to see Illumina market it as a ready to go product is quite worrying. It may burn a lot of people